Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2018 | Factors that influence the treatment decision-making of CLL patients

Here, Brian Koffman, MDCM, DCFP, DABFM, MS Ed, Founder and Medical Director of the CLL Society and CLL patient, discusses the factors that influence patients with chronic lymphocytic leukemia (CLL) when making decisions about their treatment. Dr Koffman discusses the key outcomes of a survey of over 1,000 patients, which identified the opportunity to improve the way patients are educated on clinical trial opportunities. Speaking at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA., Dr Koffman hopes that the implications of the study can lead to more tailored patient care.